Tranzactioneaza Theratechnologies (US.THTX) - 3.39 USD (%) Tranzactioneaza
Indici
Descriere companie
Theratechnologies Inc. (http://www.theratech.com/) is a Canada-based biopharmaceutical company focused on the development and commercialization of therapies addressing unmet medical needs. The Company has two approved products: EGRIFTA SV in the United States, and Trogarzo in the United States, the European Union and the United Kingdom. EGRIFTA SV (tesamorelin for injection) is developed for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy. Trogarzo (ibalizumab-uiyk) is developed for HIV treatment. The treatment is infused every two weeks. It is a new class of antiretrovirals (ARV), and is a long-acting ARV therapy that can lead to an undetectable viral load in combination with other ARVs. The Company markets its prescription products in the United States, Europe and Canada. Its research pipeline is focused on specialized therapies addressing unmet medical needs in HIV, oncology and non-alcoholic steatohepatitis (NASH).